MOL PLUS has decided to invest in Pyxis Maritime, a Singapore-based developer of electric vessels and operator of electric ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...

In collaboration with the Government of Singapore, Japan and Australia the IMF organizes courses for officials from countries in the Asia-Pacific region at the STI, which was established in 1998.

The International Fact-Checking Network (IFCN) leverages the expertise of its team, Poynter faculty, signatories and global partners to provide fact-checkers with the tools and resources they need to ...

The award recipients will be honored at the OWA’s annual Champagne Breakfast on Wednesday, March 11, 2026, during ...